Last updated on July 2020

Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL


Brief description of study

This study will assess whether there are differences in effectiveness and safety outcomes among PI3K-treated patients in a real world registry, compared to patients treated in clinical trials.

Detailed Study Description

Phase IV, multicenter, prospective observational study in a real world (RW) setting, designed to observe the utilization and effectiveness of PI3K-inhibitor treatment, and HRQoL of patients with CLL/SLL/FL outside the context of a clinical trial.

Clinical Study Identifier: NCT04342117

Find a site near you

Start Over

Hattiesburg Clinic, PA

Hattiesburg, MS United States
  Connect »

Oncology Hematology Associates

Springfield, MO United States
  Connect »

CARTI Cancer Center

Little Rock, AR United States
  Connect »

Goshen General Hospital

Goshen, IN United States
  Connect »

McFarland Clinic,PC

Ames, IA United States
  Connect »

Capital Region Medical Center

Jefferson City, MO United States
  Connect »

NY Cancer and Blood Specialists

Port Jefferson Station, NY United States
  Connect »

St. Agnes Hospital

Baltimore, MD United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.